Education
About Us
Working with TipRanks
Follow Us
Lexicon Pharmaceuticals (LXRX)
NASDAQ:LXRX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 31.08M | $ 1.20M | $ 139.00K | $ 298.00K | $ 24.00M |
| Gross Profit | $ 30.46M | $ 1.12M | $ -288.00K | $ -54.75M | $ 22.07M |
| Operating Income | $ -197.12M | $ -171.75M | $ -100.76M | $ -87.09M | $ -178.78M |
| EBITDA | $ -184.29M | $ -163.46M | $ -98.74M | $ -86.66M | $ -41.10M |
| Net Income | $ -200.40M | $ -177.12M | $ -103.13M | $ -88.27M | $ -70.18M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 237.96M | $ 170.03M | $ 138.36M | $ 86.74M | $ 152.28M |
| Total Assets | $ 298.42M | $ 229.43M | $ 194.30M | $ 136.91M | $ 203.79M |
| Total Debt | $ 108.40M | $ 106.06M | $ 55.29M | $ 2.28M | $ 12.81M |
| Net Debt | $ 41.74M | $ 83.60M | $ 8.95M | $ -61.79M | $ -113.45M |
| Total Liabilities | $ 152.47M | $ 136.32M | $ 77.17M | $ 23.31M | $ 47.42M |
| Stockholders' Equity | $ 145.95M | $ 93.11M | $ 117.12M | $ -1.49B | $ 156.37M |
| Cash Flow | |||||
| Free Cash Flow | $ -179.81M | $ -162.37M | $ -90.18M | $ -88.24M | $ -143.06M |
| Operating Cash Flow | $ -178.78M | $ -161.90M | $ -88.85M | $ -87.02M | $ -142.97M |
| Investing Cash Flow | $ -15.38M | $ -49.94M | $ -71.08M | $ 2.11M | $ 380.76M |
| Financing Cash Flow | $ 238.35M | $ 187.96M | $ 142.21M | $ 22.71M | $ -147.64M |